U rinary tract infections (UTIs) are among the most common bacterial infections of humans and a significant burden on global healthcare. A major issue is recurrence, as approximately 25% of women who suffer UTI will experience recurrent UTI (rUTI) within six months of initial infection. The problem is magnified by emerging antibiotic resistance 1 . Most UTIs (~70%) are caused by uropathogenic Escherichia coli (UPEC), which possesses virulence factors that facilitate infection, including fimbriae that permit attachment to the urothelium, toxins that damage the host, systems to acquire iron in an iron-limited environment, and polysaccharide surface coatings that provide resistance against innate immune factors 2 . Current knowledge of UTI pathogenesis is largely derived from mouse-model studies 3 that have elucidated processes of adherence, invasion, intracellular growth and exfoliation of UPEC into the bladder lumen
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Bacterial infection of the bladder can lead to mucosal remodelling and increased predisposition to recurrent infection, changing the way we view host susceptibility and providing new opportunities to develop novel therapeutics.
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during acute UTI 2 ( Fig. 1a) , but few models have been applied to study rUTI 4 . In this issue of Nature Microbiology, O'Brien et al. 5 show that an initial UTI can leave an enduring molecular imprint on the bladder through urothelial remodelling and transcriptional rewiring that comprises cyclooxygenase-2 (COX-2)-dependent inflammation. This discovery provides new insight into how initial infection can cause remodelling of the innate immune system and how this can influence the outcome of subsequent infections.
The authors found that an initial bladder infection with UPEC resulted in two different outcomes: (1) spontaneous resolution (Fig. 1b) , which was associated with a reduced incidence of rUTI ('resolved' mice), or (2) persistent (chronic) infection (Fig. 1c) , which led to increased susceptibility to subsequent infection and a greater incidence of rUTI ('sensitized' mice). Sensitization was long-lasting (up to 6 months) and occurred in two different models of chronic UTI. Interestingly, sensitization increased susceptibility to different UPEC strains and Klebsiella, but did not increase susceptibility to the asymptomatic bacteriuria E. coli strain 83972 or the gut commensal E. coli strain Nissle 1917. Thus, some components of the UPEC virulence armoury are required for rUTI to occur in the sensitized bladder. It also remains to be determined if multiple repeat episodes of rUTI, as experienced by many women, can cause sensitization that predisposes subjects to infection that is caused by less virulent strains.
By examining the mechanisms of bladder sensitization, the authors found that the urothelium in sensitized mice displayed altered architecture, distinct transcriptomic and proteomic signatures, and a predisposition for inflammation (Fig. 1c) . They exploited the findings to explore rUTIprevention strategies in sensitized mice and established that targeting COX-2 as a checkpoint for inflammation or vaccination with the FimH adhesin of type 1 fimbriae could prevent severe rUTI and acute and chronic cystitis in sensitized mice, respectively. The authors concluded that COX-2 expression in the bladder during the first 24 hours following UTI, as noted in prior studies [6] [7] [8] , is the probable determinative factor of acute outcomes in sensitized mice 5 . Understanding innate immune responses to UTI will be crucial in defining susceptibility to rUTI. Mediators that are known to help control the rheostat for governing the extent of the innate immune response include interferon regulatory factors 3 and 7 (Irf3 and Irf7) 9 , but neither of these genes were differentially expressed between sensitized and resolved mice. 14 , which is neither innate nor adaptive and has been described in the context of recurrent papillomavirus infection and repeat exposure to Plasmodium. While antigenspecific responses can accelerate UPEC clearance in the bladder 15 , this work is the first to associate the concept of trained immunity with rUTI.
Overall, the study by O'Brien et al. reveals a new paradigm for how a history of UTI can radically alter innate immune responses in ways that impact future infection, suggesting the existence of pathogen-driven mechanisms that exploit a heightened state of host susceptibility to benefit the pathogenic lifestyle. As successful bacterial pathogens associated with recurrent infections deploy multiple strategies to avoid innate and adaptive defence mechanisms, future studies of rUTI might thus explore the role of specific UPEC virulence factors that may 'remodel' the bladder innate immune response. ❐
